UNSPSC 51282413: Carbenicillin disodium

This classification denotes an extended spectrum penicillin antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9TS4B3H261. European Medicines Agency schedules Carbenicillin disodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01041MIG. Carbenicillin disodium generally arises in the molecular formula C17H16N2NA2O6S. The term 'carbenicillin disodium' is a Japanese Accepted Name designation.

Most nations, for tariff and trade purposes, schedule carbenicillin disodium under HS 29411090 and SITC 54131. As of Q4 2014, CARBENICILLIN DISODIUM remains US FDA's Preferred Term for this commodity. Carbenicillin disodium bears US NLM identifiers UMLS ID C0813202 and NCI Concept Code C65285. SMILES: CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)C(C3CCCCC3)C(=O)[O-])C(=O)[O-])C.[NA+].[NA+].

UNSPSC 51282413 Carbenicillin disodium is a Commodity code that nominally describes a specific antibiotic pharmaceutical ingredient, but recent state and local solicitations tagged under this code show minimal alignment with that scope. The two opportunities in the recent activity block involve procurement of finished pharmaceutical products—antibiotic tablets (doxycycline and ciprofloxacin) and naloxone—rather than carbenicillin disodium as an active pharmaceutical ingredient or bulk chemical. State and local health departments and county health agencies issue opportunities under this code, typically through cooperative purchasing vehicles (such as MMCAP Infuse consortium agreements) or competitive IFB processes to supply pharmaceutical inventories to public health operations and community health programs.

The geographic activity documented includes Illinois (the Illinois Department of Public Health awarded a $2,999,999.11 contract to Chartwell Rx LLC through MMCAP Infuse on August 28, 2026, for supply of doxycycline and ciprofloxacin tablets over 12 months with renewal options through year 3) and Florida (Seminole County issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries). The Illinois opportunity closed on September 11, 2026, and the Seminole County opportunity closed on July 26, 2023 (this record shows a historic date misalignment in the source). The code shows sparse recent relevant activity; most opportunities recorded under this Commodity code do not track carbenicillin disodium procurement specifically but instead capture broader pharmaceutical supply and distribution activity through state and local health purchasing channels.